Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Greyson G W Biegert

2PUBLICATIONS

10CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Mar 29, 2023

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies.

Daniel Wang, Caroline E Porter, Bora Lim

|Jun 10, 2022

HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy.

Amanda Rosewell Shaw, Caroline Porter, Greyson Biegert

Pageof 1

Frequent Collaborators

2 joint publications

Masataka Suzuki

1 joint publications

Daniel Wang

1 joint publications

Caroline E Porter

1 joint publications

Bora Lim

1 joint publications

Amanda Rosewell Shaw

1 joint publications

Mae L Woods

1 joint publications

Ya Xu

1 joint publications

Tao Wang

1 joint publications

Helen Heslop

1 joint publications

Malcolm K Brenner

Frequent Collaborators

2 joint publications

Masataka Suzuki

1 joint publications

Daniel Wang

1 joint publications

Caroline E Porter

1 joint publications

Bora Lim

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos